BiotechTube

Nivolumab + 5-azacytidine

Phase 1/2UNKNOWN
0 views this week 0 watching💤 Quiet
Interest: 28/100
28
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

AML, Childhood

Conditions

AML, Childhood

Trial Timeline

Nov 29, 2019 → Mar 30, 2024

NCT ID
NCT03825367

About Nivolumab + 5-azacytidine

Nivolumab + 5-azacytidine is a phase 1/2 stage product being developed by Bristol Myers Squibb for AML, Childhood. The current trial status is unknown. This product is registered under clinical trial identifier NCT03825367. Target conditions include AML, Childhood.

What happened to similar drugs?

1 of 5 similar drugs in AML, Childhood were approved

Approved (1) Terminated (0) Active (4)
🔄Obinutuzumab + MMF + Prednisone + Methylprednisolone + Acetaminophen/ Paracetamol + Diphenhydramine HydrochlorideRochePhase 3
✅SemaglutideNovo NordiskApproved
🔄Brivaracetam Film-coated tablet + Brivaracetam oral solutionUCBPhase 3
🔄Brivaracetam Film-coated tablet + Brivaracetam oral solutionUCBPhase 3
🔄BrivaracetamUCBPhase 3

Hype Score Breakdown

Clinical
9
Activity
4
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT03825367Phase 1/2UNKNOWN

Competing Products

20 competing products in AML, Childhood

See all competitors
ProductCompanyStageHype Score
LY2940680 + LY2940680Eli LillyPhase 1
21
Panobinostat + Cytarabine + PanobinostatNovartisPhase 1
29
Obinutuzumab + MMF + Prednisone + Methylprednisolone + Acetaminophen/ Paracetamol + Diphenhydramine HydrochlorideRochePhase 3
44
Rituximab + PlaceboRochePhase 2/3
38
BlinatumomabAmgenPhase 2
27
SemaglutideNovo NordiskApproved
50
Temsirolimus + Etoposide + Cyclophosphamide + Methotrexate + Hydrocortisone + CytarabinePfizerPhase 1
29
Talazoparib + Irinotecan + Temozolomide + Filgrastim + Peg-filgrastimPfizerPhase 1
29
CrizotinibPfizerPhase 1/2
32
carboplatin + irinotecan hydrochlorideBristol Myers SquibbPhase 1
29
Vinblastine + Cyclophosphamide + Capecitabine + NivolumabBristol Myers SquibbPhase 1/2
36
Paxalisib + Opdualag + Irinotecan (drug) + Temozolomide (TMZ)Bristol Myers SquibbPhase 1/2
39
Clofarabine incorporated into a 5-drug regimenSanofiPhase 1
29
Brivaracetam Film-coated tablet + Brivaracetam oral solutionUCBPhase 3
47
Brivaracetam Film-coated tablet + Brivaracetam oral solutionUCBPhase 3
40
BrivaracetamUCBPhase 3
44
Sodium OxybateJazz PharmaceuticalsPhase 1/2
29
Modified Measles Virus + Modified Measles Virus Lumbar PunctureBrain BiotechPhase 1
19
palbociclib isethionateBrain BiotechPhase 1
11
Cytarabine + Fludarabine + Hydrocortisone Sodium Succinate + Imetelstat + Leucovorin Calcium + MethotrexateGeronPhase 1
30